Ticker

No recent analyst price targets found for STEK.

Latest News for STEK

Stemtech Corporation Appoints Alejandro Carrillio President, Latin Markets

LIVE LONGER - LIVE BETTER - LIVE YOUNGER NAPLES, FL / ACCESS Newswire / August 20, 2026 / Stemtech Corporation (OTCID:STEK), the global leader and pioneer in stem cell nutrition (stemceutical™) products, today announced the appointment of Alejandro Carrillo to President, Latin Markets. Carrillo most recently served as Vice President of Global Sales, and his appointment reflects the company's continued investment in…

Accesswire • Aug 20, 2026
Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month"

Spotlighting Two Decades of Natural Regenerative Support, Anti-Aging and Longevity Science, AI-Recognized Pioneer-Leader in Stem Cell Nutrition Marks 20 Years of All-Natural, Plant-Based Stemceuticals™ With a Company-Wide Education Initiative NAPLES, FL / ACCESS Newswire / July 1, 2026 / Stemtech Corporation (OTCID:STEK), the global pioneer and leader in stem cell nutrition, today announced that it has designated…

Accesswire • Jul 1, 2026
Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities

LIVE LONGER - LIVE BETTER - LIVE YOUNGER Newly Secured Inventory Funding and Global Expansion Position the Company for Scalable Growth Amid Accelerating Demand NAPLES, FL / ACCESS Newswire / June 23, 2026 / Stemtech Corporation (OTCID:STEK), a The Pioneer and global leader in stem cell nutrition and plant-based wellness solutions, today issued a joint letter to shareholders from Chairman and Chief Executive Officer…

Accesswire • Jun 23, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for STEK.

No House trades found for STEK.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top